Stay updated on Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as a topic, and MedlinePlus Genetics is added under related topics. The site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-11T17:41:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Related topic links for 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the related topics section.
    Difference
    0.1%
    Check dated 2026-02-25T09:01:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated the page metadata to include related topics for Multiple Myeloma and MedlinePlus Genetics and adjusted date-stamped entries (2026-02-12, 2026-02-13) while removing older timestamps (2026-01-16, 2026-01-15, 2026-01). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-18T04:19:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the older Revision: v3.4.1, the government funding status notice, and related topic references (Multiple myeloma and MedlinePlus Genetics).
    Difference
    0.5%
    Check dated 2026-02-11T02:24:52.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    - Added a government funding status notice banner and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:30:06.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The updates add a glossary toggle and several metadata/version notes (Last Update Submitted that Met QC Criteria, Last Update Posted, and Revision: v3.4.0) while removing earlier QC-related fields and older revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:19:22.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab with Bispecific Antibodies Clinical Trial page.